Your shopping cart is currently empty

EGFR-IN-113 (compound II-1) is an EGFR kinase inhibitor with an IC50 of 14.79 μM. It induces apoptosis and inhibits cell proliferation by downregulating the Akt and Erk1/2 signaling pathways. EGFR-IN-113 is applicable in research on EGFR-driven cancers, such as lung cancer, pancreatic cancer, and breast cancer.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | EGFR-IN-113 (compound II-1) is an EGFR kinase inhibitor with an IC50 of 14.79 μM. It induces apoptosis and inhibits cell proliferation by downregulating the Akt and Erk1/2 signaling pathways. EGFR-IN-113 is applicable in research on EGFR-driven cancers, such as lung cancer, pancreatic cancer, and breast cancer. |
| Molecular Weight | 627.07 |
| Formula | C31H32ClFN4O7 |
| Cas No. | 2549192-10-9 |
| Smiles | O=C(OCCCOC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4)C=5C=C(O)C=C(O)C5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.